Venetoclax Combined With Azactidine in the Treatment of ALAL

NCT05901974 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia of Ambiguous Lineage

Interventions

DRUG: Venetoclax
DRUG: azactidine

Sponsor

Sheng-Li Xue, MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]